Cibc World Market Inc. grew its holdings in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 56.2% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 212,866 shares of the company’s stock after buying an additional 76,602 shares during the period. Cibc World Market Inc.’s holdings in Colgate-Palmolive were worth $18,162,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently added to or reduced their stakes in the company. Bridges Investment Management Inc. raised its stake in shares of Colgate-Palmolive by 1.8% during the third quarter. Bridges Investment Management Inc. now owns 11,062 shares of the company’s stock valued at $944,000 after purchasing an additional 200 shares during the period. Edgestream Partners L.P. bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $5,018,000. Banco Santander S.A. boosted its stake in Colgate-Palmolive by 4.0% during the 3rd quarter. Banco Santander S.A. now owns 6,663 shares of the company’s stock valued at $568,000 after purchasing an additional 257 shares in the last quarter. First Financial Bankshares Inc boosted its stake in shares of Colgate-Palmolive by 31.1% during the 3rd quarter. First Financial Bankshares Inc now owns 11,765 shares of the company’s stock worth $1,004,000 after acquiring an additional 2,794 shares in the last quarter. Finally, BCS Private Wealth Management Inc. grew its holdings in shares of Colgate-Palmolive by 46.9% during the third quarter. BCS Private Wealth Management Inc. now owns 8,408 shares of the company’s stock valued at $717,000 after buying an additional 2,683 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Trading Down 2.0%
CL opened at $96.84 on Friday. The company has a market cap of $76.98 billion, a P/E ratio of 25.48, a PEG ratio of 4.48 and a beta of 0.31. The company has a current ratio of 0.96, a quick ratio of 0.63 and a debt-to-equity ratio of 11.23. The company’s 50 day moving average is $91.80 and its 200-day moving average is $90.51. Colgate-Palmolive Company has a 1-year low of $75.96 and a 1-year high of $101.81.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, October 30th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The company had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.34 billion. During the same quarter last year, the firm posted $0.91 EPS. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive Company will post 3.92 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Tuesday, October 20th were paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 83.14%.
Insider Transactions at Colgate-Palmolive
In related news, insider John Hazlin sold 23,376 shares of Colgate-Palmolive stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $99.15, for a total value of $2,317,730.40. Following the transaction, the insider directly owned 27,021 shares of the company’s stock, valued at $2,679,132.15. The trade was a 46.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Panagiotis Tsourapas sold 19,938 shares of the stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $98.74, for a total transaction of $1,968,678.12. Following the completion of the transaction, the chief operating officer directly owned 9,111 shares of the company’s stock, valued at approximately $899,620.14. The trade was a 68.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 77,414 shares of company stock worth $7,613,786. 0.43% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Several equities analysts recently issued reports on CL shares. Evercore boosted their price target on Colgate-Palmolive from $100.00 to $101.00 and gave the company an “outperform” rating in a research note on Thursday, October 8th. Morgan Stanley boosted their target price on Colgate-Palmolive from $104.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, November 2nd. Raymond James Financial boosted their price target on shares of Colgate-Palmolive from $100.00 to $102.00 and gave the company an “outperform” rating in a report on Monday, August 3rd. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $104.00 to $102.00 and set an “overweight” rating for the company in a report on Monday, November 2nd. Finally, Sanford C. Bernstein reiterated a “market perform” rating on shares of Colgate-Palmolive in a report on Thursday, August 13th. Thirteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $101.22.
View Our Latest Stock Analysis on CL
Colgate-Palmolive Company Profile
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
